logo-large
  • Browse Categories

Publications by authors named "Mario Rodenas-Rovira"

Claim this Profile
V
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.
Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull, Rebeca Rodriguez-Veiga, Marina Lopez-Nogueroles, Mario Rodenas-Rovira

Eur J Clin Pharmacol· November 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of voriconazole treatment in paediatric patients with fungal endocarditis: a pharmacokinetics case report.
Mario Rodenas-Rovira, Mayte Gil-Candel, Inés Burgos-Berjillos, Catalina Montoya-Tamayo, Javier Garcia-Pellicer

Eur J Hosp Pharm· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study.
Antonio Solana-Altabella, Irene Navarro-Vicente, Eduardo Rodríguez-Arbolí, Victor Noriega, Josefina Serrano, Mario Rodenas-Rovira

Cancers (Basel)· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: